Morphology and distribution of neurons expressing serotonin 5-HT1A receptors in the rat hypothalamus and the surrounding diencephalic and telencephalic areas

Journal of Chemical Neuroanatomy

Volumn 39, Issue 4, 2010, Pages 235-241

  Marvin, Eric ^a   Scrogin, Karie ^b   Dudas B ^a  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Circadian rhythm; Feeding; Immunohistochemistry; Mood; Neuroendocrine functions; Sleep

Indexed keywords

SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL FUNCTION; CELL LABELING; CELL SIZE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIENCEPHALON; EXPERIMENTAL ANIMAL; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION; TELENCEPHALON;

AFFECT; ANIMALS; BRAIN MAPPING; CELL SHAPE; CIRCADIAN RHYTHM; DIENCEPHALON; FEEDING BEHAVIOR; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEURAL PATHWAYS; NEURONS; NEUROSECRETORY SYSTEMS; RATS; RATS, INBRED F344; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SLEEP; TELENCEPHALON;

EID: 77951023234     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2010.01.003     Document Type: Article

References (63)

1. Amir S., Robinson B., Ratovitski T., Rea M.A., Stewart J., Simantov R. A role for serotonin in the circadian system revealed by the distribution of serotonin transporter and light-induced Fos immunoreactivity in the suprachiasmatic nucleus and intergeniculate leaflet. Neuroscience 1998, 84(4):1059-1073.
2. 1A) partial agonist in the treatment of major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 1992, 16(3):271-280.
3. Azmitia E.C., Gannon P.J., Kheck N.M., Whitaker-Azmitia P.M. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 1996, 14(1):35-46.
4. Barabanova S.V., Fedotova I., Sapronov N.S. Effects of antagonists of 1A and 2A/2C subtypes of serotonin receptors on the depressive behavior and expression of c-Fos protein in hypothalamus of ovariectomized rats. Eksp. Klin. Farmakol. 2007, 70(2):3-7.
5. Blier P., De M.C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 1994, 15(7):220-226.
6. Bradbury M.J., Dement W.C., Edgar D.M. Serotonin-containing fibers in the suprachiasmatic hypothalamus attenuate light-induced phase delays in mice. Brain Res. 1997, 768(1-2):125-134.
7. 1A receptor ligands-past and present. Curr. Med. Chem. 2005, 12(15):1721-1753.
8. Centeno M.L., Sanchez R.L., Cameron J.L., Bethea C.L. Hypothalamic expression of serotonin 1A, 2A and 2C receptor and GAD67 mRNA in female cynomolgus monkeys with different sensitivity to stress. Brain Res. 2007, 1142:1-12.
9. Collin M., Backberg M., Onnestam K., Meister B. 5-HT1A receptor immunoreactivity in hypothalamic neurons involved in body weight control. Neuroreport 2002, 13(7):945-951.
10. Cuesta M., Mendoza J., Clesse D., Pevet P., Challet E. Serotonergic activation potentiates light resetting of the main circadian clock and alters clock gene expression in a diurnal rodent. Exp. Neurol. 2008, 210(2):501-513.
11. Curzon G. Serotonin and appetite. Ann. N. Y. Acad. Sci. 1990, 600:521-530.
12. de Souza V., Menani J.V., de Arruda Camargo G.M., de Arruda Camargo L.A., Saad W.A. Activation of the serotonergic 5-HT1A receptor in the paraventricular nucleus of the hypothalamus inhibits water intake and increases urinary excretion in water-deprived rats. Regul. Pept. 2008, 150(1-3):14-20.
13. Derry C., Benjamin C., Bladin P., le B.D., Tochon-Danguy H., Berkovic S.F., Zimmer L., Costes N., Mulligan R., Reutens D. Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy. Neuroimage 2006, 30(2):341-348.
14. Eison A.S., Eison M.S. Serotonergic mechanisms in anxiety. Prog. Neuropsychopharmacol. Biol. Psychiatry 1994, 18(1):47-62.
15. Ferris C.F., Melloni R.H., Koppel G., Perry K.W., Fuller R.W., Delville Y. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J. Neurosci. 1997, 17(11):4331-4340.
16. Fetissov S.O., Meguid M.M., Chen C., Miyata G. Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats. Neuroscience 2000, 101(3):657-663.
17. Gallyas F., Gorcs T., Merchenthaler I. High-grade intensification of the end-product of the diaminobenzidine reaction for peroxidase histochemistry. J. Histochem. Cytochem. 1982, 30(2):183-184.
18. 1A agonist, in normal volunteers. Psychopharmacology (Berl.) 1994, 116(4):433-436.
19. Glaser T., Traber J. Buspirone: action on serotonin receptors in calf hippocampus. Eur. J. Pharmacol. 1983, 88(1):137-138.
20. Gundlah C., Pecins-Thompson M., Schutzer W.E., Bethea C.L. Ovarian steroid effects on serotonin 1A, 2A and 2C receptor mRNA in macaque hypothalamus. Brain Res. Mol. Brain Res. 1999, 63(2):325-339.
21. Horiuchi J., McDowall L.M., Dampney R.A. Differential control of cardiac and sympathetic vasomotor activity from the dorsomedial hypothalamus. Clin. Exp. Pharmacol. Physiol. 2006, 33(12):1265-1268.
22. Hutson P.H., Donohoe T.P., Curzon G. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology (Berl.) 1988, 95(4):550-552.
23. Hutson P.H., Dourish C.T., Curzon G. Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur. J. Pharmacol. 1988, 150(3):361-366.
24. Jimenez A.E., Walker R.F. Circadian patterns of serotonin (5-HT) accumulation after pargyline treatment in the rat hypothalamus during development. Int. J. Dev. Neurosci. 1988, 6(2):203-209.
25. Jorgensen H., Kjaer A., Knigge U., Moller M., Warberg J. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J. Neuroendocrinol. 2003, 15(6):564-571.
26. Jorgensen H., Riis M., Knigge U., Kjaer A., Warberg J. Serotonin receptors involved in vasopressin and oxytocin secretion. J. Neuroendocrinol. 2003, 15(3):242-249.
27. Jorgensen H.S. Studies on the neuroendocrine role of serotonin. Dan. Med. Bull. 2007, 54(4):266-288.
28. Kallo I., Liposits Z., Flerko B., Coen C.W. Immunocytochemical characterization of afferents to estrogen receptor-containing neurons in the medial preoptic area of the rat. Neuroscience 1992, 50(2):299-308.
29. Kia H.K., Brisorgueil M.J., Daval G., Langlois X., Hamon M., Verge D. Serotonin1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca-a double immunocytochemical study. Neuroscience 1996, 74(1):143-154.
30. Kia H.K., Brisorgueil M.J., Hamon M., Calas A., Verge D. Ultrastructural localization of 5-hydroxytryptamine1A receptors in the rat brain. J. Neurosci. Res. 1996, 46(6):697-708.
31. Kia H.K., Miquel M.C., Brisorgueil M.J., Daval G., Riad M., El M.S., Hamon M., Verge D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J. Comp. Neurol. 1996, 365(2):289-305.
32. Kindlundh-Hogberg A.M., Svenningsson P., Schioth H.B. Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain. Neuropharmacology 2006, 51(4):838-847.
33. Kiss J., Csaky A., Halasz B. Demonstration of serotoninergic axon terminals on somatostatin-immunoreactive neurons of the anterior periventricular nucleus of the rat hypothalamus. Brain Res. 1988, 442(1):23-32.
34. Kiss J., Halasz B. Demonstration of serotoninergic axons terminating on luteinizing hormone-releasing hormone neurons in the preoptic area of the rat using a combination of immunocytochemistry and high resolution autoradiography. Neuroscience 1985, 14(1):69-78.
35. Kiss J., Halasz B. Synaptic connections between serotoninergic axon terminals and tyrosine hydroxylase-immunoreactive neurons in the arcuate nucleus of the rat hypothalamus. A combination of electron microscopic autoradiography and immunocytochemistry. Brain Res. 1986, 364(2):284-294.
36. Kiss J., Leranth C., Halasz B. Serotoninergic endings on VIP-neurons in the suprachiasmatic nucleus and on ACTH-neurons in the arcuate nucleus of the rat hypothalamus. A combination of high resolution autoradiography and electron microscopic immunocytochemistry. Neurosci. Lett. 1984, 44(2):119-124.
37. Li Q., Battaglia G., Van de Kar L.D. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine. Brain Res. 1997, 769(1):141-151.
38. Li Q., Muma N.A., Battaglia G., Van de Kar L.D. A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of G(i) and G(o) proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors. J. Pharmacol. Exp. Ther. 1997, 282(3):1581-1590.
39. Liposits Z., Phelix C., Paull W.K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 1987, 86(6):541-549.
40. Ljubic-Thibal V., Morin A., Diksic M., Hamel E. Origin of the serotonergic innervation to the rat dorsolateral hypothalamus: retrograde transport of cholera toxin and upregulation of tryptophan hydroxylase mRNA expression following selective nerve terminals lesion. Synapse 1999, 32(3):177-186.
41. Mancilla-Diaz J.M., Escartin-Perez R.E., Lopez-Alonso V.E., Floran-Garduno B., Romano-Camacho J.B. Role of 5-HT1A and 5-HT1B receptors in the hypophagic effect of 5-HT on the structure of feeding behavior. Med. Sci. Monit. 2005, 11(3):BR74-BR79.
42. McMillen B.A., Scott S.M., Williams H.L., Sanghera M.K. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission. Naunyn Schmiedebergs Arch. Pharmacol. 1987, 335(4):454-464.
43. Mizuta T., Segawa T. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis. Jpn. J. Pharmacol. 1989, 50(3):315-326.
44. Moore R.Y., Speh J.C. Serotonin innervation of the primate suprachiasmatic nucleus. Brain Res. 2004, 1010(1-2):169-173.
45. Nomura K., Castanon-Cervantes O., Davidson A., Fukuhara C. Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts. Life Sci. 2008, 82(23-24):1169-1174.
46. Oberndorfer S., Saletu-Zyhlarz G., Saletu B. Effects of selective serotonin reuptake inhibitors on objective and subjective sleep quality. Neuropsychobiology 2000, 42(2):69-81.
47. Osei-Owusu P., James A., Crane J., Scrogin K.E. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. J. Pharmacol. Exp. Ther. 2005, 313(3):1324-1330.
48. Petrov T., Krukoff T.L., Jhamandas J.H. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res. 1994, 277(2):289-295.
49. Pinato L., Allemandi W., Abe L.K., Frazao R., Cruz-Rizzolo R.J., Cavalcante J.S., Costa M.S., Nogueira M.I. A comparative study of cytoarchitecture and serotonergic afferents in the suprachiasmatic nucleus of primates (Cebus apella and Callithrix jacchus) and rats (Wistar and Long Evans strains). Brain Res. 2007, 1149:101-110.
50. Ricci L.A., Rasakham K., Grimes J.M., Melloni R.H. Serotonin-1A receptor activity and expression modulate adolescent anabolic/androgenic steroid-induced aggression in hamsters. Pharmacol. Biochem. Behav. 2006, 85(1):1-11.
51. Roberts A.J., McArthur R.A., Hull E.E., Post C., Koob G.F. Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol. Psychopharmacology (Berl.) 1998, 137(1):25-32.
52. Sawaguchi T., Ozawa Y., Patricia F., Kadhim H., Groswasser J., Sottiaux M., Takashima S., Nishida H., Kahn A. Serotonergic receptors in the midbrain correlated with physiological data on sleep apnea in SIDS victims. Early Hum. Dev. 2003, 75(Suppl.):S65-S74.
53. Spencer D.G., Glaser T., Traber J. Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine. Psychopharmacology (Berl.) 1987, 93(2):158-166.
54. Steffens S.M., da Cunha I.C., Beckman D., Lopes A.P., Faria M.S., Marino-Neto J., Paschoalini M.A. The effects of metergoline and 8-OH-DPAT injections into arcuate nucleus and lateral hypothalamic area on feeding in female rats during the estrous cycle. Physiol Behav. 2008, 95(3):484-491.
55. Steinbusch H.W. Serotonin-immunoreactive neurons and their projections in the CNS. Handbook of Chemical Neuroanatomy 1984, 68-125. Elsevier, Amsterdam. A. Bjorklund, T. Hokfelt, M.J. Kuhar (Eds.).
56. Steinbusch H.W., Nieuwenhuys R. Localization of serotonin-like immunoreactivity in the central nervous system and pituitary of the rat, with special references to the innervation of the hypothalamus. Adv. Exp. Med. Biol. 1981, 133:7-35.
57. Su J.D., Liu S.Y. Direct projections from serotonergic neurons in the dorsal and median raphe nuclei of midbrain to the suprachiasmatic nucleus in Tupaia belangeri chinensis. Neuroreport 2001, 12(11):2341-2345.
58. Swanson L.W. Brain Maps: Structure of the Rat Brain 1998, Elsevier, Amsterdam.
59. Vickers S.P., Dourish C.T. Serotonin receptor ligands and the treatment of obesity. Curr. Opin. Investig. Drugs 2004, 5(4):377-388.
60. Voigt J.P., Kienzle F., Sohr R., Rex A., Fink H. Feeding and 8-OH-DPAT-related release of serotonin in the rat lateral hypothalamus. Pharmacol. Biochem. Behav. 2000, 65(1):183-189.
61. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J. Comp. Neurol. 1995, 351(3):357-373.
62. Yamazaki S., Alones V., Irelan W., Menaker M. Serotonin-containing cell bodies in novel brain locations: effects of light input. Neuroreport 1999, 10(2):431-435.
63. Zhang Y., Gray T.S., D'Souza D.N., Carrasco G.A., Damjanoska K.J., Dudas B., Garcia F., Zainelli G.M., Sullivan Hanley N.R., Battaglia G., Muma N.A., Van de Kar L.D. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo. J. Pharmacol. Exp. Ther. 2004, 310(1):59-66.